Roberta D’Arrigo

1.4k total citations
37 papers, 957 citations indexed

About

Roberta D’Arrigo is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Roberta D’Arrigo has authored 37 papers receiving a total of 957 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Virology, 31 papers in Infectious Diseases and 9 papers in Epidemiology. Recurrent topics in Roberta D’Arrigo's work include HIV Research and Treatment (33 papers), HIV/AIDS drug development and treatment (31 papers) and HIV/AIDS Research and Interventions (14 papers). Roberta D’Arrigo is often cited by papers focused on HIV Research and Treatment (33 papers), HIV/AIDS drug development and treatment (31 papers) and HIV/AIDS Research and Interventions (14 papers). Roberta D’Arrigo collaborates with scholars based in Italy, United States and Cameroon. Roberta D’Arrigo's co-authors include Carlo Federico Perno, Francesca Ceccherini‐Silberstein, Andrea Antinori, Valentina Svicher, Caterina Gori, Anne‐Geneviève Marcelin, Isabelle Malet, Federica Forbici, Massimo Ciccozzi and Salvatore Dimonte and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Clinical Infectious Diseases.

In The Last Decade

Roberta D’Arrigo

35 papers receiving 933 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberta D’Arrigo Italy 20 735 717 261 160 87 37 957
Yoshiyuki Yokomaku Japan 20 699 1.0× 654 0.9× 366 1.4× 283 1.8× 60 0.7× 60 1.1k
Awet Abraha United States 16 1.1k 1.4× 851 1.2× 185 0.7× 188 1.2× 97 1.1× 21 1.2k
M. B. Vasudevachari United States 12 693 0.9× 550 0.8× 126 0.5× 196 1.2× 73 0.8× 21 861
C. Petropoulos United States 11 626 0.9× 555 0.8× 138 0.5× 95 0.6× 35 0.4× 17 769
Kay Limoli United States 12 1.1k 1.5× 1.1k 1.5× 165 0.6× 152 0.9× 34 0.4× 14 1.2k
Mia Coetzer United States 16 639 0.9× 440 0.6× 186 0.7× 89 0.6× 91 1.0× 25 788
Luke C. Swenson Canada 17 690 0.9× 585 0.8× 172 0.7× 144 0.9× 35 0.4× 35 834
N. Bischofberger United States 14 527 0.7× 580 0.8× 182 0.7× 322 2.0× 46 0.5× 24 930
Elly Baan Netherlands 15 768 1.0× 533 0.7× 115 0.4× 142 0.9× 32 0.4× 21 859
M. Brad Guffey United States 8 424 0.6× 348 0.5× 87 0.3× 149 0.9× 51 0.6× 9 579

Countries citing papers authored by Roberta D’Arrigo

Since Specialization
Citations

This map shows the geographic impact of Roberta D’Arrigo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta D’Arrigo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta D’Arrigo more than expected).

Fields of papers citing papers by Roberta D’Arrigo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta D’Arrigo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta D’Arrigo. The network helps show where Roberta D’Arrigo may publish in the future.

Co-authorship network of co-authors of Roberta D’Arrigo

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta D’Arrigo. A scholar is included among the top collaborators of Roberta D’Arrigo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta D’Arrigo. Roberta D’Arrigo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Scutari, Rossana, Roberta D’Arrigo, Lavinia Fabeni, et al.. (2018). The degree of HIV-1 amino acid variability is strictly related to different disease progression rates. Virus Genes. 54(4). 493–501. 2 indexed citations
2.
Armenia, Daniele, Ina Vandenbroucke, Lavinia Fabeni, et al.. (2012). Study of Genotypic and Phenotypic HIV-1 Dynamics of Integrase Mutations During Raltegravir Treatment: A Refined Analysis by Ultra-Deep 454 Pyrosequencing. The Journal of Infectious Diseases. 205(4). 557–567. 46 indexed citations
3.
Véras, Nazle Mendonça Collaço, Maria Mercedes Santoro, Rebecca Gray, et al.. (2011). Molecular Epidemiology of HIV Type 1 CRF02_AG in Cameroon and African Patients Living in Italy. AIDS Research and Human Retroviruses. 27(11). 1173–1182. 19 indexed citations
4.
5.
Fokam, Joseph, Romina Salpini, Maria Mercedes Santoro, et al.. (2011). Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon. Archives of Virology. 156(7). 1235–1243. 26 indexed citations
6.
Svicher, Valentina, E Balestra, Valeria Cento, et al.. (2011). HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro. Antiviral Research. 90(1). 42–53. 26 indexed citations
7.
Ceccherini‐Silberstein, Francesca, Isabelle Malet, Lavinia Fabeni, et al.. (2010). Specific HIV-1 integrase polymorphisms change their prevalence in untreated versus antiretroviral-treated HIV-1-infected patients, all naive to integrase inhibitors. Journal of Antimicrobial Chemotherapy. 65(11). 2305–2318. 53 indexed citations
8.
Tommasi, Chiara, Francesca Ceccherini‐Silberstein, Roberta D’Arrigo, et al.. (2010). Use of novel antiretroviral agents in rescue regimens: A case of early virological failure to raltegravir. Scandinavian Journal of Infectious Diseases. 42(3). 237–239. 1 indexed citations
9.
Sing, Tobias, Valentina Svicher, Maria Mercedes Santoro, et al.. (2009). Dynamics of NRTI Resistance Mutations during Therapy Interruption. AIDS Research and Human Retroviruses. 25(1). 57–64. 12 indexed citations
10.
Alteri, Claudia, Valentina Svicher, Caterina Gori, et al.. (2009). Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naïve to the antiretroviral drugs. BMC Infectious Diseases. 9(1). 111–111. 21 indexed citations
11.
Tozzi, Valerio, Rita Bellagamba, Filippo Castiglione, et al.. (2008). Plasma HIV RNA Decline and Emergence of Drug Resistance Mutations among Patients with Multiple Virologic Failures Receiving Resistance Testing-Guided HAART. AIDS Research and Human Retroviruses. 24(6). 787–796. 4 indexed citations
12.
Svicher, Valentina, Stefano Aquaro, Roberta D’Arrigo, et al.. (2008). Specific Enfuvirtide‐Associated Mutational Pathways in HIV‐1 Gp41 Are Significantly Correlated With an Increase in CD4+Cell Count, Despite Virological Failure. The Journal of Infectious Diseases. 197(10). 1408–1418. 35 indexed citations
13.
D’Arrigo, Roberta, Massimo Ciccozzi, Caterina Gori, et al.. (2007). gp41 Sequence Variability in HIV Type 1 Non-B Subtypes Infected Patients Undergoing Enfuvirtide Pressure. AIDS Research and Human Retroviruses. 23(10). 1296–1302. 8 indexed citations
14.
Oliveira, Túlio de, Oliver G. Pybus, Andrew Rambaut, et al.. (2006). HIV-1 and HCV sequences from Libyan outbreak. Nature. 444(7121). 836–837. 92 indexed citations
15.
Svicher, Valentina, Francesca Ceccherini‐Silberstein, Tobias Sing, et al.. (2005). Additional Mutations in HIV-1 Reverse Transcriptase are Involved in the Highly Ordered Regulation of NRTI Resistance. Max Planck Institute for Plasma Physics. 16(4). 1–1.
16.
Ciccozzi, Massimo, Caterina Gori, Stefano Boros, et al.. (2005). Molecular Diversity of HIV in Albania. The Journal of Infectious Diseases. 192(3). 475–479. 25 indexed citations
17.
Zaccarelli, Mauro, Carlo Federico Perno, Federica Forbici, et al.. (2004). Q151M‐Mediated Multinucleoside Resistance: Prevalence, Risk Factors, and Response to Salvage Therapy. Clinical Infectious Diseases. 38(3). 433–437. 23 indexed citations
18.
Ceccherini‐Silberstein, Francesca, Fulvio Erba, Federico Gago, et al.. (2004). Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure. AIDS. 18(12). 11–19. 60 indexed citations
19.
Santoro, Maria Mercedes, Francesca Ceccherini‐Silberstein, Caterina Gori, et al.. (2004). Temporal change in the use of genotypic resistance testing over the years 1999--2003.. PubMed. 27(2 Suppl 1). 141–4. 1 indexed citations
20.
Perno, Carlo Federico, Alessandra Cenci, Roberta D’Arrigo, et al.. (2003). HIV fitness and resistance as covariates associated with the appearance of mutations under antiretroviral treatment. Scandinavian Journal of Infectious Diseases. 35(11). 37–40.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshiyuki Yokomaku Breakdown of academic impact, for papers by Awet Abraha Breakdown of academic impact, for papers by M. B. Vasudevachari Breakdown of academic impact, for papers by C. Petropoulos Breakdown of academic impact, for papers by Kay Limoli Breakdown of academic impact, for papers by Mia Coetzer Breakdown of academic impact, for papers by Luke C. Swenson Breakdown of academic impact, for papers by N. Bischofberger Breakdown of academic impact, for papers by Elly Baan Breakdown of academic impact, for papers by M. Brad Guffey
Rankless by CCL
2026